Share-based Payment Arrangement, Expense in USD of Anika Therapeutics, Inc. from 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Anika Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to Q2 2025.
  • Anika Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $2.22M, a 29% decline year-over-year.
  • Anika Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $11M, a 8.69% decline year-over-year.
  • Anika Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12.2M, a 10.2% decline from 2023.
  • Anika Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.5M, a 0.54% decline from 2022.
  • Anika Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.6M, a 22.8% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Anika Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $11M $2.22M -$903K -29% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-05
Q1 2025 $11.9M $3M -$259K -7.96% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $12.2M $2.39M +$283K +13.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 $11.9M $3.39M -$167K -4.69% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $12M $3.12M -$1.03M -24.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-05
Q1 2024 $13.1M $3.25M -$463K -12.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 $13.5M $2.11M -$1M -32.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 $14.5M $3.56M -$315K -8.13% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $14.9M $4.15M +$69K +1.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $14.8M $3.72M +$1.17M +46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $13.6M $3.11M -$57K -1.8% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-17
Q3 2022 $13.7M $3.88M +$1.01M +35.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $12.7M $4.08M +$1.28M +45.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $11.4M $2.55M +$286K +12.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11.1M $3.17M +$1.73M +121% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $9.35M $2.86M +$943K +49.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $8.41M $2.8M +$557K +24.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7.85M $2.26M +$2.47M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $5.39M $1.43M -$514K -26.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 $5.9M $1.92M +$609K +46.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $5.29M $2.24M +$797K +55.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $4.49M -$207K -$1.59M -115% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $6.09M $1.95M +$965K +98.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $5.12M $1.31M +$134K +11.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $4.99M $1.44M +$121K +9.15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $4.87M $1.39M -$6.18M -81.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $11M $982K -$885K -47.4% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 $11.9M $1.18M -$297K -20.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $12.2M $1.32M +$38K +2.96% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $12.2M $7.57M +$6.38M +540% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $5.81M $1.87M +$750K +67.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $5.06M $1.47M +$677K +84.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $4.38M $1.28M +$623K +94.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $3.76M $1.18M +$365K +44.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $3.39M $1.12M +$454K +68.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $2.94M $797K +$299K +59.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $2.64M $661K +$152K +29.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $2.49M $817K +$262K +47.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $2.23M $663K +$252K +61.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $1.97M $498K +$108K +27.6% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-03
Q2 2015 $1.87M $509K +$131K +34.8% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $1.73M $555K +$127K +29.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $1.61M $411K +$268K +187% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 $1.34M $391K +$22K +5.96% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $1.32M $378K +$12.6K +3.45% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $1.3M $428K +$4.86K +1.15% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 $1.3M $143K -$94.1K -39.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $1.39M $369K +$87.7K +31.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1.31M $365K +$52.8K +16.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $1.25M $423K +$102K +32% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $1.15M $237K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $281K -$38.4K -12% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $313K +$30.5K +10.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $321K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q3 2011 $319K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $282K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07

Anika Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.2M -$1.38M -10.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $13.5M -$74K -0.54% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $13.6M +$2.53M +22.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $11.1M +$5.7M +106% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $5.39M -$701K -11.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $6.09M -$4.96M -44.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $11M +$5.24M +90.2% Jan 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
2017 $5.81M +$2.42M +71.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-06
2016 $3.39M +$1.17M +52.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $2.23M +$618K +38.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $1.61M +$307K +23.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-24
2013 $1.3M +$149K +12.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 $1.15M -$39.5K -3.32% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $1.19M +$88.1K +7.99% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-14
2010 $1.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.